Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
MammoTest Breast Biopsy System cleared as platform for breast brachytherapy
December 30th, 2004
Fischer Imaging Corp. (FIMG:PK), announced it has received clearance from the U.S. Food and Drug Administration (FDA) for use of the MammoTest Breast Biopsy System as a platform for interstitial breast brachytherapy, a new treatment for breast cancer offering a less invasive, 4-day alternative to the traditional 6-week external beam radiation therapy. Developed by Robert Kuske, MD, professor of radiation oncology at the University of Arizona, interstitial brachytherapy involves the precise, x-ray-guided insertion of catheters to irradiate and control malignant tumors in the breast using the MammoTest digital imaging system. While traditional external beam radiation...
Source: Women's Health Weekly (2004-12-30)
|
